Novo Nordisk Offering Large Discount on Wegovy in Bid to Recapture Market

Image by Armend Nimani / AFP via Getty / Futurism Developments It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy. Competitors are nipping at its heels, cheaper knockoffs have been eating into its sales, and it just gave the boot to its former CEO. Now, hoping its worst days are behind it, Novo says it's offering customers a massive discount on Wegovy, the weight-loss variant of its flagship drug semaglutide. For your first month of treatment, Reuters reports, you can nab a batch of Wegovy injections for $199 until June 30, Novo said. After that, it'll set you back $499 per month — which is still a lot of money, but the drug used to cost an outrageous $1,000 per month without insurance, so at least it's a step toward broader access. Don't mistake this for benevolence, though, or even necessarily a sign of growing desperation, though there may be a component of that as well. Instead, Novo is looking to capitalize on a ... Read full article.